In its first few months, Pfizer’s Velsipity has already made a splash in the ulcerative colitis space, where it’s up against fellow S1P Zeposia.
Eight of Eight Patients Successfully Transitioned from Oral Tacrolimus to TFF TAC with No Sign of Acute Rejection at Reduced Systemic Exposures Data from TFF VORI Phase 2 and EAP Program Continue to...
The high-profile startup, co-founded by CAR-T innovator Carl June, will use the funds to bring an autoimmune disease treatment into proof-of-concept studies.
Enforcement Report - Week of February 28, 2024
FORT WORTH, Texas, Jan. 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
Pfizer and BioNTech are ready to ship their latest updated Covid-19 vaccine throughout the EU — all they need is a nod from the European Commission.
Voriconazole Inhalation Powder (TFF VORI) is an investigational, inhaled formulation of voriconazole developed using TFF Pharmaceuticals Thin Film Freezing technology that is currently being evaluated...
Saint-Herblain (France), June 21, 2023 “ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were...
NFL BIOSCIENCES: Approval for its patent to be granted on NFL-101 in Europe and approval of the clinical development plan for NFL-101 by the EMA NFL BIOSCIENCES (Euronext Growth Paris “ FR0014003XT0...
Accord Healthcare`s Voriconazole Accord (voriconazole) Receives Approval in Europe